Overall rank by patents
#4,416
Across all tracked assignees
USPTO PatentsView assignee record - 80 granted patents across 18 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B67D (DISPENSING, DELIVERING OR TRANSFERRING LIQUIDS, NOT OTHERWISE PROVIDED FOR).
The verdict
Coravin holds 80 US patents across 18 technology areas, rank #4,416 of 50,000 tracked assignees.
Coravin, Inc. has been granted 80 US utility patents between 2015 and 2025, placing Coravin, Inc. at rank #4,416 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.4 claims per patent with primary concentration in B67D (DISPENSING, DELIVERING OR TRANSFERRING LIQUIDS, NOT OTHERWISE PROVIDED FOR). As a US Corporation, Coravin, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Coravin sits between Bayer Materialscience Ag (80 patents, rank #4,412) and IGT Canada Solutions ULC (80 patents, rank #4,420) - the closest US assignees by grant volume. The composite Innovation Score of 39.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 53 grants, compared with 27 in the 2015–2019 window, a +96% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Coravin, Inc.'s 11.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 18 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Coravin, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Bayer MaterialScience AG
80 patents
Callahan Cellular L.L.C.
80 patents
Capital One Financial Corporation
80 patents
Coherent, Inc.
80 patents
DUPONT SAFETY & CONSTRUCTION, INC.
80 patents
Draka Comteq B.V.
80 patents
EIS GmbH
80 patents
IGT Canada Solutions ULC
80 patents
Coravin, Inc.
80 patents
What this shows Coravin holds 80 patents at rank #4,416, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,416 in granted patent volume.
Other assignees with the most granted patents in Coravin's primary technology class.
Coravin's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
39 Top 38% higher than 62% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 9 | 11.3% |
| 2016 | 3 | 3.8% |
| 2017 | 5 | 6.3% |
| 2018 | 1 | 1.3% |
| 2019 | 9 | 11.3% |
| 2020 | 17 | 21.3% |
| 2021 | 18 | 22.5% |
| 2022 | 4 | 5.0% |
| 2023 | 8 | 10.0% |
| 2024 | 4 | 5.0% |
| 2025 | 2 | 2.5% |
Top 15 of 18 technology areas
Overall rank by patents
#4,416
Across all tracked assignees
39.5 out of 100
How to use this portfolio
Coravin's 80 grants land it in the top 38% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.